LivePerson Board Faces Shareholder Suit Over Poison Pill
Board members of artificial intelligence software company LivePerson face a stockholder derivative action in the Delaware Court of Chancery alleging an activist hedge fund is pushing to prevent LivePerson's sale to...To view the full article, register now.
Already a subscriber? Click here to view full article